osimertinib
astrazeneca
['nsclc', 'lung', 'tagrisso', 'sclc']
#news: #tagrisso demonstrated sustained disease-free survival in egfrm #nsclc #pharma #pharmaceutical #healthcare #globalhealth #esmo22 #esmo2022 #esmo #cancer #oncology #cancer #cancerresearch #cancertreatment #cancercare #lungcancer #oncology #patient
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma